Angiotensin II-type 2 receptor: emerging target for cardiovascular protection.
Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany. roland.schmieder@uk-erlangen.de
Roland E
RE
Schmieder
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology; D044139:Receptor, Angiotensin, Type 2 / Q000819:agonists* / Q000235:genetics / Q000378:metabolism
D044139:Receptor, Angiotensin, Type 2